AVXL
ANAVEX LIFE SCIENCES CORP.
+0.05 (+2.12%)2.41USD117K成交股數223M市值–本益比(近四季)53.0股價營收比-0.3%營收年增(近四季)2026-11-24下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 9 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.1M-0% | 1.1M-12% | 1.1M-23% | 999K-44% | 1.1M-39% | 1.2M-40% | 1.4M-29% | 1.8M-2% | 1.8M | 2.0M | 2.0M | 1.8M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | 4.2M | 4.7M | 7.3M | 10.0M | 9.9M | 10.4M | 11.8M | 9.7M | 8.7M | 10.1M | 10.3M |
| 銷售管理費用 | 2.0M | 2.3M | 2.1M | 3.5M | 4.5M | 2.6M | 3.1M | 2.8M | 2.9M | 2.7M | 2.6M | 3.2M |
| 營業利益 | 6.7M-147% | −6.5M-48% | −6.8M-50% | −10.8M-26% | −14.5M+15% | −12.5M+10% | −13.6M+7% | −14.6M+8% | −12.6M | −11.4M | −12.7M | −13.5M |
| 營業利益率 | 628.5% | -611.1% | -628.5% | -1,085.5% | -1,345.0% | -1,034.1% | -975.0% | -813.1% | -718.9% | -566.6% | -646.5% | -740.2% |
| 稅後淨利 | 7.8M-159% | −5.3M-52% | −5.7M-53% | −9.8M-20% | −13.2M+26% | −11.2M+30% | −12.1M+19% | −12.2M+8% | −10.5M | −8.6M | −10.1M | −11.3M |
| 淨利率 | 729.9% | -503.1% | -526.5% | -983.7% | -1,231.9% | -925.3% | -868.8% | -680.1% | -600.6% | -429.4% | -518.2% | -617.1% |
| 稀釋 EPS | 0.08-150% | -0.06-54% | -0.06-57% | -0.11-21% | -0.16+23% | -0.13+18% | -0.14+17% | -0.140% | -0.13 | -0.11 | -0.12 | -0.14 |
| 稀釋股數 | 92.90B | 92.7M | 89.0M | 85.3M | 85.38B | 85.1M | 84.8M | 84.5M | 82.5M | 82.1M | 79.8M | 80.9M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 118M | 127M | 132M | 103M | 101M | 116M | 121M | 139M | 139M | 144M | 151M | 155M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 120M | 129M | 133M | 104M | 102M | 117M | 124M | 142M | 145M | 148M | 154M | 158M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 7.7M | 7.1M | 6.4M | 8.9M | 11.5M | 17.4M | 13.1M | 11.8M | 9.6M | 12.5M | 12.5M | 11.1M |
| 股東權益 | 112M | 122M | 127M | 94.9M | 91.0M | 99.8M | 111M | 130M | 135M | 136M | 142M | 147M |
| 負債比 | 6.4% | 5.5% | 4.8% | 8.6% | 11.2% | 14.8% | 10.6% | 8.3% | 6.6% | 8.4% | 8.1% | 7.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | −7.2M-41% | – | – | – | −12.1M | – | – | −7.3M | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 4.7M | -36.1% | −46.4M | -991.4% | -0.54 | – |
| FY2024 | 7.3M | +12.3% | −43.0M | -587.5% | -0.52 | – |
| FY2023 | 6.5M | +588.4% | −47.5M | -728.7% | -0.60 | – |
| FY2022 | 947K | +3542.3% | −48.0M | -5,066.3% | -0.62 | – |
| FY2021 | 26K | -85.6% | −37.9M | -145,803.8% | -0.54 | – |
| FY2020 | 180K | -13.2% | −26.3M | -14,602.5% | -0.45 | – |
| FY2019 | 207K | -18.7% | −26.3M | -12,685.7% | -0.54 | – |
| FY2018 | 255K | – | −17.3M | -6,763.3% | -0.39 | – |